The Two New Weight Loss Drugs Belviq and Qsymia
Obesity is a disease that can lead to other serious medical conditions it has been determined by medical researchers. It is for this reason that after 13 years, the Federal Drug Administration, or FDA, has approved two new weight loss medications called Belviq and Qsmia. Both drugs have risks, but the FDA decided that the risks associated with obesity were much worse than any risks posed.
Both will be prescribed for losing weight, yet they are nothing alike. So, if you are planning to take one of these drugs to shed some stubborn fat, be informed about each one, and then compare them. By the way, Belviq is pronounced BEL-VEEK, and Qsymia is pronounced KYOO-SIM-UH.
Qysmia will be offered only for women on birth control by certified pharmacies, but will probably be available at large chain online pharmacy websites. It will be available sometime near the end of 2012. Belviq is expected to be in the US pharmacies by early 2013.
Belviq and Qsymia are radically different chemically. Qsymia is composed of two drugs: phentermine and topiramate. Phentermine is an appetite suppressant. It actually triggers the flow of norpinephrine in the brain. It triggers the release of more than the usual leptin in your blood stream, which is a hormone regulator of your appetite.
The topiramate in Qysmia causes you to lose weight in three ways: a feeling of being satiated, food is less appetizing, and the metabolism speeds up to burn more calories. This drug is also effective in treating seizures and migraine headaches.
Belviq causes you to lose weight by catalyzing higher amounts of serotonin, which serves as a messenger in your brain. It’s labeled a controlled substance by the FDA because it contains phentermine. At above prescribed doses, the phentermine can cause hallucinations.
The FDA recommends both Qsymia and Belviq for the same conditions: People with a body mass index, or BMI, of 30 or higher, and for those overweight, meaning a BMI at 27 or higher plus a related condition. This could be a condition such as hypertension, high cholesterol, or type II diabetes.
Qsymia and Belviq are both very effective for losing excessive weight. They have not been tested in a one-on-one research test as yet. Both drugs had a significantly higher number of people lose weight than those on a placebo when a controlled clinical test was undergone. The test for each drug’s effectiveness had different measurements and controls, so any comparison from the testing would be invalid.
In conclusion, both Qysmia and Belviq are highly effective for losing excess weight. The FDA says that once you’re taking either Qsymia or Belviq, you should have it as a dietary medication for the remainder of your life. You should only halt taking either drug if side effects occur. The medical community and the FDA urge you to eat a well-rounded diet, and get at least ten minutes of light exercise daily for optimal effectiveness of Qysmia or Belviq. You will have the benefit of being much healthier as well.
Written and researched by Gerald Rivers, Fitness Expert